BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35507043)

  • 1. Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives.
    Pervaiz A; Jan MS; Hassan Shah SM; Khan A; Zafar R; Ansari B; Shahid M; Hussain F; Ijaz Khan M; Zeb A; Mukarram Shah SM
    J Biomol Struct Dyn; 2022 May; ():1-14. PubMed ID: 35507043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives.
    Ahmad A; Ullah F; Sadiq A; Ayaz M; Saeed Jan M; Shahid M; Wadood A; Mahmood F; Rashid U; Ullah R; Sahibzada MUK; Alqahtani AS; Mahmood HM
    Drug Des Devel Ther; 2020; 14():2165-2178. PubMed ID: 32606589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinimide Derivatives as Antioxidant Anticholinesterases, Anti-
    Alshehri OM; Mahnashi MH; Sadiq A; Zafar R; Jan MS; Ullah F; Alshehri MA; Alshamrani S; Hassan EE
    Evid Based Complement Alternat Med; 2022; 2022():6726438. PubMed ID: 35942378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel antipyrine based α-aminophosphonates as anti-Alzheimer and anti-inflammatory agent.
    Shaikh S; Dhavan P; Singh P; Uparkar J; Vaidya SP; Jadhav BL; Ramana MMV
    J Biomol Struct Dyn; 2023 Feb; 41(2):386-401. PubMed ID: 34878960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies.
    Fatima B; Saleem F; Salar U; Chigurupati S; Felemban SG; Ul-Haq Z; Tariq SS; Almahmoud SA; Taha M; Shah STA; Khan KM
    Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300384. PubMed ID: 37806747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies.
    Ahmad A; Ullah F; Sadiq A; Ayaz M; Rahim H; Rashid U; Ahmad S; Jan MS; Ullah R; Shahat AA; Mahmood HM
    Drug Des Devel Ther; 2019; 13():4185-4194. PubMed ID: 31849450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
    Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
    Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterocyclic compounds with different moieties: synthesis and evaluation of biological activities assisted with the computational study.
    Kısa D; Koç E; Baş Topcu KS; İmamoğlu R
    J Biomol Struct Dyn; 2023 Oct; ():1-10. PubMed ID: 37840315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.
    Mughal EU; Sadiq A; Ayub M; Naeem N; Javid A; Sumrra SH; Zafar MN; Khan BA; Malik FP; Ahmed I
    J Biomol Struct Dyn; 2021 Oct; 39(16):6154-6167. PubMed ID: 32752941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
    Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
    Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
    Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation and
    Zahoor M; Khan I; Zeb A; Sahibzada MUK; Naz S; Bari WU; Kamran AW
    Heliyon; 2021 Feb; 7(2):e06367. PubMed ID: 33681505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of carbazole based α-aminophosphonate derivatives: design, molecular docking and
    Shaikh S; Dhavan P; Singh P; Uparkar J; Vaidya SP; Jadhav BL; Ramana MV
    J Biomol Struct Dyn; 2022 Jul; 40(11):4801-4814. PubMed ID: 33345710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies.
    Maqbool M; Solangi M; Khan KM; Özil M; Baltaş N; Salar U; Tariq SS; Haq ZU; Taha M
    Arch Pharm (Weinheim); 2024 Jun; ():e2400325. PubMed ID: 38885529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
    Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
    Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities.
    Puopolo T; Liu C; Ma H; Seeram NP
    Med Cannabis Cannabinoids; 2022; 5(1):85-94. PubMed ID: 35702400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors.
    Shaaban MA; Kamal AM; Faggal SI; Farag NA; Aborehab NM; Elsahar AE; Mohamed KO
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000027. PubMed ID: 32696514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors.
    Hawash M; Jaradat N; Abualhasan M; Şüküroğlu MK; Qaoud MT; Kahraman DC; Daraghmeh H; Maslamani L; Sawafta M; Ratrout A; Issa L
    BMC Chem; 2023 Mar; 17(1):11. PubMed ID: 36879343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.